We are live on ! Find out more
BCDAW

BioCardia, Inc. Warrant
BCDAW

Delisted

BCDAW was delisted on the 2nd of August, 2024.

Back to rankings

4 hedge funds and large institutions have $1.45K invested in BioCardia, Inc. Warrant in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $1.22K → $1.45K (+$234)

20% less funds holding

Funds holding: 5 → 4 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$40
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
1
Citadel Advisors
Florida
$667 -$40 -2,060 -4%
Osaic Holdings
2
Osaic Holdings
Arizona
$465 – – –
G
3
GenTrust
Florida
$232 – – –
Bank of America
4
Bank of America
North Carolina
$86 – – –

BCDAW Hedge Fund Activity: Q1 2024 in Review

4 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in BioCardia, Inc. Warrant (BCDAW) for Q1 2024, worth a combined $1.45K — up 19% from $1.22K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BCDAW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.

The largest seller was Citadel Advisors, cutting an estimated $40.

  • 4 institutional investors held BioCardia, Inc. Warrant (BCDAW) as of Q1 2024, down from 5 in Q4 2023.
  • Funds reported $1.45K of BioCardia, Inc. Warrant stock for Q1 2024, up 19% quarter-over-quarter.
  • 0 funds opened new BioCardia, Inc. Warrant positions in Q1 2024 and 1 closed out, a net change of -1 holder.
  • The largest BioCardia, Inc. Warrant seller in Q1 2024 was Citadel Advisors, an estimated $40 sold.

Based on aggregated 13F filings for Q1 2024.